Table 2.
CircRNA | Cancer | Functions | Sponge miRNA | Targets | PD-1/PD-L1 | Reference |
---|---|---|---|---|---|---|
Hsa_circ_0000190 | NSCLC | Indicates poor survival and prognosis | N/S | N/S | Increases PD-L1 | [114] |
CircFGFR1 | Indicates poor prognosis and survival | miR-381-3p | CXCR4 | Resistance to anti-PD-1 immunotherapy | [115] | |
Circ-CPA4 | Indicates poor prognosis, inactives CD8 + T cells | let-7 | N/S | Increases PD-L1 | [118] | |
Circ_0000284 | Induces cell migration, invasion and proliferation | miR-377 | N/S | Increases PD-L1 | [120] | |
Hsa_circ_0020397 | CRC | Induces cell viability and invasion, inhibits cell apoptosis | miR-138 | TERT | Increases PD-L1 | [121] |
CDR1-AS | CRC | Related to poor prognosis | Independent on miR-7 | CMTM4, CMTM6 | Increases PD-L1 | [122] |
Circ_0020710 | Mel | Induces cell proliferation, migration, invasion; inhibits cytotoxic lymphocyte exhaustion | miR-370-3p | CXCL12/CXCR4/CXCR7 | Immune suppressive | [123] |
Circ-UBAP2 | PAAD | Inhibits antigen presentation; induces immune escape | miR-494 | CXCR4 and ZEB1 | Increases CTLA-4 and PD-1 | [124] |
Mel Melanoma, NSCLC Non-small-cell lung cancer, PAAD Pancreatic adenocarcinoma